Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma.
Journal Information
Full Title: Appl Immunohistochem Mol Morphol
Abbreviation: Appl Immunohistochem Mol Morphol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Histocytochemistry
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The authors thank Kate Sojka for critical review and editing of the manuscript; Andrew Segal for critical review of the manuscript; Dako histology team for procurement of tissues and preparation of cut sections for this study, especially Lenka Van Alphen; Tissue samples were provided by the Cooperative Human Tissue Network which is funded by the National Cancer Institute. Other investigators may have received specimens from the same subjects; tissue samples supplied by Asterand Bioscience; Dako operations team for the production of the reagents for this assay; and Grace Kim, Erika Klohe, and Sam An for project management support. Supported by Bristol-Myers Squibb."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025